Pfizer Inc (NYSE:PFE)
| 32.08 Delayed Data As of Sep 28 |  -0.02 / -0.06%Today’s Change | 31.77 Today|||52-Week Range 54.93 | -37.39% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 48.9B | 52.8B | 52.5B | 53.6B | |
| Cost of Goods Sold | 8.0B | 10.2B | 9.5B | 9.6B | ||
| Depreciation And Amortization | 5.2B | 5.8B | 6.3B | 6.4B | ||
| Operating Expenses | Gross Income | 35.7B | 36.9B | 36.8B | 37.6B | |
| General Expenses | 22.4B | 22.6B | 22.3B | 22.4B | ||
| Research And Development | 7.7B | 7.8B | 7.6B | 8.0B | ||
| Total Operating Expenses | 35.6B | 38.6B | 38.1B | 38.4B | ||
| Non-Operating Expenses | Operating Income | 13.3B | 14.3B | 14.4B | 15.3B | |
| Extraordinary Credit | 0.00 | 0.00 | 62.0M | 1.2B | ||
| Extraordinary Charge | -4.0B | -6.7B | -2.7B | -4.8B | ||
| Pre-Tax Equity Earnings | 45.0M | -- | 0.00 | -- | ||
| Interest Expense On Debt | 1.2B | 1.2B | 1.3B | 1.4B | ||
| Other Expenses | 321.0M | 1.4B | 1.4B | 1.2B | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 9.0B | 8.4B | 12.3B | 11.9B | |
| Income Taxes | -2.0B | -1.1B | -9.0B | -706.0M | ||
| Minority Interest | -26.0M | -31.0M | -47.0M | -36.0M | ||
| Preferred Dividend | -1.0M | -1.0M | -1.0M | -1.0M | ||
| Discontinued Operations | 17.0M | 17.0M | -1.0M | 10.0M | ||
| Extraordinary Items | -6.0M | 0.00 | 3.0M | 0.00 | ||
| Net Income | 7.0B | 7.2B | 21.3B | 11.2B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 6.2B | 6.1B | 6.0B | 5.9B | |
| Shares To Calculate EPS Diluted | 6.3B | 6.2B | 6.1B | 6.0B | ||
| Earnings Per Share | EPS | $1.11 | $1.17 | $3.52 | $1.87 | |
| EPS Diluted | $1.11 | $1.17 | $3.52 | $1.87 | ||